These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18480038)

  • 1. A cost-effectiveness framework for profiling the value of hospital care.
    Timbie JW; Newhouse JP; Rosenthal MB; Normand SL
    Med Decis Making; 2008; 28(3):419-34. PubMed ID: 18480038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods for combining quality and efficiency performance measures: profiling the value of hospital care following acute myocardial infarction.
    Timbie JW; Normand SL
    Stat Med; 2008 Apr; 27(9):1351-70. PubMed ID: 17922491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of "risk-adjusted" hospital outcomes.
    Shahian DM; Normand SL
    Circulation; 2008 Apr; 117(15):1955-63. PubMed ID: 18391106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite measures for hospital quality using quality-adjusted life years.
    Timbie JW; Shahian DM; Newhouse JP; Rosenthal MB; Normand SL
    Stat Med; 2009 Apr; 28(8):1238-54. PubMed ID: 19184974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The quality assessment from the minimum basic hospital discharge data set].
    Peiró S; Librero J
    Rev Neurol; 1999 Oct 1-15; 29(7):651-61. PubMed ID: 10599116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L; Zhang Z; Zhang W; Ewen E; Jurkovitz C; Leguet P; Kolm P; Weintraub WS
    J Am Coll Cardiol; 2009 Sep; 54(14):1271-9. PubMed ID: 19778669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.
    Coyle D; Buxton MJ; O'Brien BJ
    Health Econ; 2003 May; 12(5):421-7. PubMed ID: 12720259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the costs, benefits, cost-effectiveness, and cost-benefit of psychological assessment: we should, we can, and here's how.
    Yates BT; Taub J
    Psychol Assess; 2003 Dec; 15(4):478-95. PubMed ID: 14692844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
    Negrín MA; Vázquez-Polo FJ
    J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness with multiple outcomes.
    Bjørner J; Keiding H
    Health Econ; 2004 Dec; 13(12):1181-90. PubMed ID: 15386670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A propensity score approach to estimating the cost-effectiveness of medical therapies from observational data.
    Mitra N; Indurkhya A
    Health Econ; 2005 Aug; 14(8):805-15. PubMed ID: 15791679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of 'comprehensive geriatric assessment (CGA)' implementation on the effectiveness and cost (CEA) of healthcare in an acute geriatric ward.
    Soejono CH
    Acta Med Indones; 2008 Jan; 40(1):3-10. PubMed ID: 19054877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving efficiency and value in palliative care with net benefit regression: an introduction to a simple method for cost-effectiveness analysis with person-level data.
    Hoch JS
    J Pain Symptom Manage; 2009 Jul; 38(1):54-61. PubMed ID: 19615627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.